Malignant Neoplasm of Stomach Completed Phase 2 Trials for Cisplatin (DB00515)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01187212Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment EvaluationTreatment
NCT00394433Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerTreatment
NCT00857246Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric CancerTreatment
NCT00601705Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or StomachTreatment
NCT01715233Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.Treatment
NCT02726399Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric CancerTreatment
NCT00215644Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric CancerTreatment
NCT00515411Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaTreatment
NCT01461057A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric CancerTreatment
NCT00003298Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric CancerTreatment
NCT00003237Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or StomachTreatment
NCT00003055Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerTreatment
NCT00002722High-Dose Chemotherapy in Treating Patients With Advanced Stomach CancerTreatment
NCT00002783Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach CancerTreatment
NCT00004103Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach CancerTreatment
NCT00003862Chemotherapy and Radiation Therapy in Treating Patients With Stomach CancerTreatment
NCT00005049Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerTreatment
NCT00004873Combination Chemotherapy in Treating Patients With Advanced Stomach CancerTreatment
NCT00006038Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerTreatment
NCT00011960Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone SurgeryTreatment
NCT00009880Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or StomachTreatment
NCT00033657Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal CancerTreatment
NCT00165464Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerTreatment
NCT00215995Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasTreatment
NCT00397904Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinTreatment
NCT00415168Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric CancerTreatment
NCT00454636A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.Treatment
NCT00477711A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerTreatment
NCT00675194Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric CancerTreatment
NCT00718913Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric CancerTreatment
NCT00737438Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaTreatment
NCT00952497A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric CancerTreatment
NCT01286766Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric AdenocarcinomaTreatment
NCT01360086Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionTreatment
NCT01388790Cetuximab in Combination With S-1 and Cisplatin in Gastric CancerTreatment
NCT01444521Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric CancerTreatment
NCT01517009A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric CancerTreatment
NCT01854255Intraperitoneal Aerosol Chemotherapy in Gastric CancerTreatment